Luminescence (RLU) 13132MA The Caspase-Glo® 1 Inflammasome Assay provides a luminogenic caspase-1 substrate, Z-WEHD-aminoluciferin, in a lytic reagent optimized for caspase-1 activity and luciferase activity. A single addition of the reagent results in cell lysis, substrate cleavage by caspase-1 and generation of light by Ultra-Glo™ Recombinant Luciferase. Inclusion of the proteasome inhibitor MG-132 in the reagent eliminates nonspecific proteasome-mediated cleavage of the substrate, enabling sensitive measurement of caspase-1 activity. The caspase-1 selective inhibitor, Ac-YVAD-CHO, can be added in parallel wells to confirm caspase-1 specific activity. Benefits: • Quick, Easy-to-Perform Assay: No sample preparation required. Add the Caspase-Glo® 1 Reagent directly to cells or culture medium in multiwell plates, and measure luminescence after only 1 hour. Less time and labor required than for Western blot or ELISA. No need for multiple pipetting steps. • Accurate Determination of Caspase-1 Activity: The assay measures only catalytically active caspase-1, enabling precise time courses of enzyme function. Westerns and ELISAs don’t necessarily monitor active enzyme. Citation Available: Read a publication by an early tester. Caspase-Glo® 1 Inflammasome Assay monitors caspase-1 activity in peripheral blood mononuclear cell (PBMC) supernatant. 18,000 16,000 10,000 12,000 14,000 8,000 6,000 2,000 4,000 0 No caspase-1 inhibitor Ac-YVAD-CHO Ordering Info enews | January 2016 medium LPS, 100ng LPS, 1µg medium + ATP LPS, 100ng, + ATP LPS, 1µg, + ATP Pagina 10

Pagina 12

Interactieve digi krant, deze weekblad of verenigingsblad is levensecht online geplaatst met Online Touch en bied het digitaal op uw website plaatsen van online sportbladen.

Promega Biotech AB - Monthly online Magazine - January 2016 edition Lees publicatie 10Home


You need flash player to view this online publication